This opportunity has expired. It is therefore no longer possible to like or apply.
See similar opportunities insteadYour career starts on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
Description
AtriCure, Inc. provides innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of long standing persistent Afib. Additionally, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
POSITION SUMMARY:
The Director, Corporate Compliance, EMEA, will manage the corporate compliance program for AtriCure Europe, B.V., which operates throughout Europe, the Middle East and Africa (EMEA). In this role, you will lead the corporate compliance program to ensure business practices and activities of AtriCure and its business partners throughout the EMEA are in compliance with related AtriCure internal policies, local laws and regulations, relevant industry standards (e.g., the MedTech Europe Code of Ethical Business Practices), and applicable US laws, with the focus on laws, rules, regulations and standards concerning anti-corruption, privacy, data protection, healthcare provider interactions, transparency, and promotion of medical devices. You will serve as a strategic business partner for management and coach towards all covered employees, to assure that the company culture of compliance is a natural element in day-to-day business. Position is located in Amsterdam.
ESSENTIAL FUNCTIONS OF THE POSITION:
This description outlines the major recurring responsibilities of the position and is not intended to be all-inclusive. Other related job objectives, special assignments and less significant responsibilities will typically be expected of you. Your main responsibility will be to partner with company executive leadership to ensure that the compliance program effectively prevents and/or detects violations of law, regulations, policies, or the AtriCure, Inc. Code of Conduct for the EMEA region by:
ADDITIONAL ESSENTIAL FUNCTIONS OF THE POSITION:
BASIC QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
AtriCure is an Equal Employment Opportunity/Affirmative Action employer and provides Drug Free Workplaces. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national or ethnic origin, age, protected veteran status, status as an individual with disability, sexual orientation, gender identity or any other characteristic protected by federal, state, or local law(s).
AtriCure participates in the federal E-Verify program to confirm the identity of and employment authorization of all newly hired employees. For further information about the E-Verify program, please click here https://www.e-verify.gov/
AtriCure has a variety of benefits available for US based employees and their families. Examples include Medical & Dental beginning day 1 of employment, 401K plus match, 15 days of paid Parental Leave, in addition to maternity leave, for new moms and dads, Volunteer Time off, Pet Insurance, and more. Corporate-based employees also have full access to our on-site fitness center and cafeteria. To see a complete list of our benefits, please visit our careers website: https://www.atricure.com/benefits
Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date.
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.